0314 GMT - IHH Healthcare's long-term prospects may remain optimistic, given its strategic plan for organic and inorganic growth, RHB IB analyst Oong Chun Sung says in a note. The healthcare service provider is targeting 4,000 new beds by 2028, with key expansion focussed on Malaysia and India, he notes. Oong cuts IHH's 2025-2026 earnings forecast by 3% and 1%, respectively, to factor in higher finance costs. RHB cuts IHH Healthcare's target price to MYR8.70 from MYR9.10 as its 2024 earnings came in below estimates, while maintaining a buy rating on the stock. Shares are 1.1% higher at MYR7.39. (yingxian.wong@wsj.com)
(END) Dow Jones Newswires
February 27, 2025 22:14 ET (03:14 GMT)
Copyright (c) 2025 Dow Jones & Company, Inc.